These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract]. Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237 [TBL] [Abstract][Full Text] [Related]
44. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis. Takasaki E Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654 [TBL] [Abstract][Full Text] [Related]
45. Clinical evaluation of renal lithiasis. Van Den Berg CJ Geriatrics; 1979 Jul; 34(7):35-42. PubMed ID: 447082 [TBL] [Abstract][Full Text] [Related]
46. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. Sakhaee K; Poindexter JR; Griffith CS; Pak CY J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008 [TBL] [Abstract][Full Text] [Related]
47. [Urolithiasis, with special reference to metabolic disorders of uric acid and oxalate]. Nihon Jinzo Gakkai Shi; 1984 Jul; 26(7):629-40. PubMed ID: 6513164 [No Abstract] [Full Text] [Related]
48. Findings in kidney stone patients. Metabolic and clinical anomalies. Experience in Greece. Kallistratos G; Marketos S; Lapatzanis P; Demopoulos K Scand J Urol Nephrol Suppl; 1980; 53():195-7. PubMed ID: 6937996 [No Abstract] [Full Text] [Related]
50. [Urolithiasis - a review of pathophysiology, diagnostic procedures and therapy (author's transl)]. Schwille PO; Scholz D; Sigel A Wien Klin Wochenschr; 1980 Jun; 92(12):411-20. PubMed ID: 6999748 [TBL] [Abstract][Full Text] [Related]
51. Biochemical aspects of urinary stones. Rose GA Proc R Soc Med; 1977 Aug; 70(8):517-20. PubMed ID: 918063 [No Abstract] [Full Text] [Related]
52. [Prevention of urinary calculi by means of a benzbromarone-citrate combination]. Bach D; Hesse A; Strenge A; Vahlensieck W Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567 [TBL] [Abstract][Full Text] [Related]
53. Proceedings: Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease and relationship to urolithiasis. Farmer RG; Mir-Madjlessi SH; Kiser WS Gut; 1973 Oct; 14(10):828. PubMed ID: 4758698 [No Abstract] [Full Text] [Related]
54. [Acidification of the urine--an essential principle in infection prevention]. Bach D Fortschr Med; 1985 Apr; 103(16):421-4. PubMed ID: 3997021 [No Abstract] [Full Text] [Related]
55. [Possibilities and limitations in the prevention of urolithiasis from the pediatric viewpoint]. Wässer S; Hauschild G; Schöne D Zentralbl Chir; 1971 Jan; 96(4):136-42. PubMed ID: 5554821 [No Abstract] [Full Text] [Related]
56. [Metabolic studies during urinary diversion by way of the small intestine]. Schneider HJ; Bockhorn V Z Urol Nephrol; 1979 May; 72(5):365-74. PubMed ID: 39393 [TBL] [Abstract][Full Text] [Related]
57. [Possibilities of the conservative treatment of urinary calculi in experiment and clinic]. Ubelhör R; Gasser G Urologe; 1968; 7(1):41-6. PubMed ID: 5654488 [No Abstract] [Full Text] [Related]
58. [Renal electrolyte changes by allopurinol. A contribution in the prophylaxis of oxalic acid stones (author's transl)]. Garke P; Terhorst B Urologe A; 1974 Jul; 13(4 Pt A):166-7. PubMed ID: 4212796 [No Abstract] [Full Text] [Related]
59. The effect of hydrochlorothiazide on the renal excretion of oxalic acid and on the formation of oxalate stones in the urinary tract. Glazenburg J Arch Chir Neerl; 1971; 23(3):217-23. PubMed ID: 5121595 [No Abstract] [Full Text] [Related]
60. [Effect of Solubitrat on the excretion of so-called urinary calculus-forming factors]. Bichler KH; Korn S; Gaiser I Fortschr Med; 1982 May; 100(17):816-8. PubMed ID: 7095696 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]